A Comprehensive Analysis of the Effects of MAPK Pathway Inhibition on the Immunological Properties of Melanoma Cells

被引：0
|
作者：
Boni, A.
Fisher, J. L.
Hampton, T. H.
Yan, S.
Tafe, L. J.
Tsongalis, G. J.
Turk, M. J.
Mullins, D. W.
Brinckerhoff, C. E.
Fadul, C. E.
Ernstoff, M. S.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Geisel Med Sch Dartmouth, Lebanon, NH USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
524
引用
收藏
页码：130A / 131A
页数：2
相关论文
共 50 条
  • [1] A Comprehensive Analysis of the Effects of MAPK Pathway Inhibition on the Immunological Properties of Melanoma Cells
    Boni, A.
    Fisher, J. L.
    Hampton, T. H.
    Yan, S.
    Tafe, L. J.
    Tsongalis, G. J.
    Turk, M. J.
    Mullins, D. W.
    Brinckerhoff, C. E.
    Fadul, C. E.
    Ernstoff, M. S.
    MODERN PATHOLOGY, 2014, 27 : 130A - 131A
  • [2] Combined MAPK Pathway and HDAC Inhibition Breaks Melanoma
    Lombard, David B.
    Cierpicki, Tomasz
    Grembecka, Jolanta
    CANCER DISCOVERY, 2019, 9 (04) : 469 - 471
  • [3] MAPK pathway inhibition in melanoma: resistance three ways
    Wellbrock, Claudia
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 727 - 732
  • [4] Molecular and immunological Effects of MAPK Inhibitors in metastatic Melanoma
    Dinter, L.
    Karitzky, P.
    Tunger, A.
    Mueller, A.
    Kaeubler, T.
    Wehner, R.
    Niessner, H.
    Wanke, I.
    Beissert, S.
    Seliger, B.
    Schmitz, M.
    Meier, F.
    Westphal, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 17 - 17
  • [5] Hyperactive AKT pathway and reactivation of the MAPK/ERK pathway in melanoma cells resistant to dual BRAF and MEK inhibition
    Wang, Victoria E.
    McCormick, Frank
    Settleman, Jeffrey
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition
    Makino, Elena
    Froehlich, Lisa Marie
    Sinnberg, Tobias
    Kosnopfel, Corinna
    Sauer, Birgit
    Garbe, Claus
    Schittek, Birgit
    CELL DEATH & DISEASE, 2020, 11 (07)
  • [7] Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition
    Elena Makino
    Lisa Marie Fröhlich
    Tobias Sinnberg
    Corinna Kosnopfel
    Birgit Sauer
    Claus Garbe
    Birgit Schittek
    Cell Death & Disease, 11
  • [8] Inhibition of RSK family members can effectively target malignant melanoma cells with MAPK pathway hyperactivation
    Kosnopfel, C.
    Sinnberg, T.
    Niessner, H.
    Sauer, B.
    Makino, E.
    Schmitt, A.
    Hailfinger, S.
    Dunn, S. E.
    Garbe, C.
    Schittek, B.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E93 - E93
  • [9] Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition
    Guardamagna, Mora
    Berciano-Guerrero, Miguel-Angel
    Villaescusa-Gonzalez, Beatriz
    Perez-Ruiz, Elisabeth
    Oliver, Javier
    Lavado-Valenzuela, Rocio
    Rueda-Dominguez, Antonio
    Barragan, Isabel
    Isabel Queipo-Ortuno, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [10] Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
    A Roesch
    Oncogene, 2015, 34 : 2951 - 2957
12345